Antimicrobial agents | Numbers of CoNS with MICa | Resistant isolates (%) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
≤0.12 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | ||
Ampicillin | 24 | 13 | 11 | 62 | 55 | 27 | 0 | 0 | 43 | 18 | 2 | 218 (85.5%) |
Trimethoprim–sulfomethoxazole | 11 | 37 | 19 | 15 | 0 | 0 | 0 | 0 | 0 | 70 | 103 | 173 (67.8%) |
Amoxicillin–clavulanic acid | 101 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 87 | 127 (49.8%) |
Oxacillin | 53 | 136 | 0 | 0 | 0 | 47 | 0 | 0 | 19 | 0 | 0 | 66 (25.9%) |
Ciprofloxacin | 84 | 43 | 14 | 0 | 52 | 0 | 7 | 24 | 9 | 9 | 13 | 62 (24.3%) |
Ofloxacin | 21 | 12 | 22 | 69 | 121 | 0 | 0 | 0 | 0 | 0 | 10 | 10 (3.9%) |
Gentamicin | 15 | 151 | 16 | 26 | 10 | 0 | 21 | 7 | 0 | 0 | 0 | 37 (14.5%) |
Erythromycin | 98 | 91 | 15 | 0 | 0 | 0 | 0 | 6 | 0 | 40 | 0 | 46 (18.0%) |
Cefotaximeb | 0 | 181 | 20 | 0 | 0 | 49 | 0 | 0 | 0 | 3 | 2 | – |